The problem with daily long-term therapy is that while BPC-157 and TB-500 have an abundance of science behind their roles in tissue repair, which is exactly what theyre intended for, for ongoing wellness without a diagnosis of injury they are likely far beyond the dose-response curve at which beneficial effects can be proven
Such imbalances may also contribute to other pathological states, including the early stages of neurodegeneration
Among those defects, treatment of intrabony defects has been studied and very well researched with randomized controlled clinical trials and long-term studies [16,17,18,19,20,21]
Key finding: AOD 9604 increased type I collagen synthesis 2.1-fold and decreased MMP-1 expression by 64% in human fibroblasts
The reporting odds ratio and its advantages over the proportional reporting ratio
Shipping was quick I was not expecting the medication to come out red but it has B12 in it